투관침 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 칩별, 용도별, 지역별, 부문 예측(2025-2030년)

Trocars Market Size, Share & Trends Analysis Report By Product, By Tip, By Application, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,194,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,571,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,325,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

투관침 시장의 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계 투관침 시장 규모는 2030년에 11억 2,000만 달러에 이를 것으로 예상되며, 2025-2030년에 걸쳐 CAGR 5.43%로 성장할 것으로 예측됩니다.

노인 증가, 복강경 수술 의존도 증가, 선진국의 유리한 상환 조치는 시장의 주요 성장 자극 요인의 일부입니다.

정부 및 주요 기업의 수술 장비 및 기구에 대한 호의적인 상환 시책이 예측 기간 동안 시장 성장을 뒷받침할 것으로 예측되고 있습니다. 거울 수술과 낮은 침습 수술에 대한 상환으로 의료 제공업체를 지원하는 상환 지원 프로그램을 실시했습니다.

게다가 세계의 노인 증가로 수술 건수는 비약적으로 증가하고 있습니다.

투관침 시장 보고서 하이라이트

• 세계 시장에서는 상당한 기술 혁신이 진행되고 있으며, 주요 기업은 항상 새로운 기술과 테크닉을 개발 및 발표하고 있습니다.
• 투관침은 캐뉼라, 씰, 칩이 금속 또는 비블레이드제의 옵츄레이터로 구성되는 의료기기입니다.
• 제품별로는 일회용 투관침 부문이 2024년에 63.75%의 최대 수익 점유율로 시장을 선도했습니다.
• 첨단부에서는 블레이드리스 트로칼 부문이 2024년에 35.4%의 최대 수익 점유율로 시장을 차지했습니다.
• 용도별로는 일반 외과 부문이 2024년의 수익으로 최대의 점유율을 차지해 시장을 리드했습니다.
• 북미의 투관침 산업은 2024년에 31.53%의 수익 점유율로 세계를 지배했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 투관침 시장의 변수, 동향, 범위

• 시장 계통의 전망
  • 모 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 투관침 시장 분석 도구
  • 산업 분석 - Porter's Five Forces 분석
  • PESTEL 분석
  • 가격 분석

제4장 투관침 시장 : 제품별, 추정·동향 분석

• 부문 대시보드
• 투관침 시장 : 제품 변동 분석과 시장 점유율, 2024년과 2030년
• 투관침 시장 규모와 동향 분석(제품별, 2018-2030년)
• 일회용 투관침
• 재사용 가능한 투관침

제5장 투관침 시장 : 칩별, 추정·동향 분석

• 부문 대시보드
• 투관침 시장 : 첨단 변동 분석과 시장 점유율, 2024년과 2030년
• 투관침 시장 규모와 동향 분석(칩별, 2018-2030년)
• 칼날 없음 투관침
• 광학 투관침
• 둔각 투관침
• 칼날 부착 투관침

제6장 투관침 시장 : 용도별, 추정·동향 분석

• 부문 대시보드
• 투관침 시장 : 용도 변동 분석과 시장 점유율, 2024년과 2030년
• 투관침 시장 규모와 동향 분석(용도별, 2018-2030년)
• 일반 외과
• 부인과 수술
• 비뇨기과 수술
• 소아외과
• 기타 수술

제7장 투관침 시장 : 제품, 칩, 용도에 따른 지역별, 추정 및 동향 분석

• 지역별 시장 점유율 분석, 2024, 2030
• 지역별 시장 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 주요 시장 진출기업에 의한 최근의 동향과 영향 분석
• 기업/경쟁의 분류
• 벤더 상황
  • 주요 리셀러와 채널 파트너 목록
  • 주요 기업의 시장 점유율 분석, 2024년
  • Teleflex Incorporated
  • The Cooper Companies Inc.
  • Molnlycke Health Care AB
  • Medtronic
  • B. Braun Medical Inc.
  • Johnson & Johnson Service, Inc.
  • Purple Surgical
  • Applied Medical Resources Corporation
  • LaproSurge

SHW

영문 목차

영문목차

Trocars Market Growth & Trends:

The global trocars market size is estimated to reach USD 1.12 billion in 2030 and is projected to grow at a CAGR of 5.43% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising geriatric population, increasing reliance on laparoscopic surgeries, and favorable reimbursement policies in developed countries are some of the primary growth stimulants for the market.

Favorable reimbursement policies by governments and key players for surgical devices and instruments are projected to boost the growth of the market over the forecast period. Key players are providing favorable reimbursement policies in order to promote minimally invasive surgeries, laparoscopic surgeries, and bariatric surgeries. For instance, Ethicon (subsidiary of Johnson & Johnson) conducts Reimbursement Support Program to help healthcare providers with reimbursement related to laparoscopic surgeries and minimally invasive surgeries. These initiatives are most likely to help healthcare providers to take up these procedures instead of traditional ones. Thus, these factors are likely to drive the market over the forecast period.

In addition, the volume of surgeries has increased manifolds due to increasing geriatric population worldwide. Geriatric population are prone to various diseases, which require various surgical interventions for treatment. According to estimates published by WHO, the global elderly population is likely to increase from 841.0 million in 2014 to more than 2.0 billion by 2050.

Trocars Market Report Highlights:

• There is a considerable degree of innovation in the global market; key players are constantly developing and releasing new techniques and technologies
• A trocar is a medical device that consists of a cannula, a seal, and an obturator with a metal or non-bladed tip. The trocar is an entry point for various tools, including staplers, scissors, and graspers.
• Based on product, the disposable trocars segment led the market with the largest revenue share of 63.75% in 2024. This dominance can be attributed to its growing importance in laparoscopic surgery and diagnostic laparoscopy.
• Based on tip, the bladeless trocars segment held the market with the largest revenue share of 35.4% in 2024. In the coming years, bladeless trocars are expected to be the most well-known market category
• In terms of application, the general surgery segment led the market with the largest share of revenue in 2024. This dominance can be attributed to the increasing number of surgical procedures and demand for trocars.
• North America trocars industry dominated globally with a revenue share of 31.53% in 2024. Moreover, competition among key players in terms of product innovation is expected to impact market dynamics.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Tip
  • 1.2.3. Application
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Tip outlook
  • 2.2.3. Application outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Trocars Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing reliance on laparoscopy
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Increasing surgical volume
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Risk of complication
    • 3.2.2.2. Product Recall
• 3.3. Trocars Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pricing Analysis

Chapter 4. Trocars Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Trocars Market: Product Movement Analysis & Market Share, 2024 & 2030
• 4.3. Trocars Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Disposable Trocars
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Reusable Trocars
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Trocars Market: Tip Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Trocars Market: Tip Movement Analysis & Market Share, 2024 & 2030
• 5.3. Trocars Market Size & Trend Analysis, by Tip, 2018 to 2030 (USD Million)
• 5.4. Bladeless Trocars
  • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Optical Trocars
  • 5.5.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Blunt Trocars
  • 5.6.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Bladed Trocars
  • 5.7.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Trocars Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Trocars Market: Application Movement Analysis & Market Share, 2024 & 2030
• 6.3. Trocars Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. General Surgery
  • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
• 6.5. Gynecological Surgery
  • 6.5.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Urological Surgery
  • 6.6.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Pediatric Surgery
  • 6.7.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Other Surgeries
  • 6.8.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Trocars Market: Regional Estimates & Trend Analysis by Product, Tip, and Application

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Mexico
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. UK
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. France
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Italy
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Spain
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Norway
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework/ reimbursement structure
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Regulatory framework/ reimbursement structure
    • 7.5.8.3. Competitive scenario
    • 7.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Australia
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Argentina
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework/ reimbursement structure
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework/ reimbursement structure
    • 7.8.4.3. Competitive scenario
    • 7.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2024
  • 8.3.4. Teleflex Incorporated
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. The Cooper Companies Inc.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Molnlycke Health Care AB
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Medtronic
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. B. Braun Medical Inc.
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Johnson & Johnson Service, Inc.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Purple Surgical
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Applied Medical Resources Corporation
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. LaproSurge
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives

관련자료